Fiche du document
Auteur
Date
7 novembre 2022
Discipline
Type de document
Périmètre
Identifiant
- handle: 10670/1.5qutu4
Source
Organisation
Sujets proches
Therapy Kahler's disease Plasma cell myelomaCiter ce document
lsgilbert, « New gene therapy to treat adult patients with multiple myeloma », ELSIBI, ID : 10670/1.5qutu4
Métriques
Partage / Export
Résumé
EMA has recommended a conditional marketing authorisation in the European Union for Carvykti for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least three prior therapies and whose cancer has worsened since they received their last treatment. Read this news published by the European Medicines Agency on 25 March 2022.